Board Meeting-Closure of Trading Window
It may please be noted that in compliance with the SEBI (Prohibition to Insider Trading) Regulations and Company''s Code of Conduct for prevention of Insider Trading, the Trading Window of the Company has been kept closed from 24th July, 2018 to 3rd August, 2018 (both days inclusive). This closure of the Trading Window has been occasioned by reason of the meeting of the Board of Directors of the Company, which is scheduled to be held on... Shareholding for the Period Ended June 30, 2018
Poly Medicure Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Avinash ChandraDesignation :- Company Secretary and Compliance Officer Announcement under Regulation 30 (LODR)-Acquisition
With reference of the captioned subject, we would like to inform you that Poly Medicure B.V., Netherlands, a subsidiary of Poly Medicure Limited, has entered into a Share Purchase Agreement with Plan 1 Health S.R.L., Italy to acquire 82% (Eighty Two) Share Capital of Plan 1 Health S.R.L., Italy. Plan 1 Health S.R.L. will become a 'subsidiary' of Poly Medicure B.V. and in turn an 'indirect subsidiary' of Poly Medicure Limited as and when... Focus on Poly Medicure's Europian subsidiary
Poly Medicure has incorporated a subsidiary Poly Medicure B.V. in Amsterdam, Netherlands. Earlier in November, the company had informed the exchanges Furnishing Of Information As Per SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 And All Other SEBI Regulations As Applicable.
Further to our letter dated 4th November, 2017, This is to inform you that a Subsidiary Company with the name and style of ' POLY MEDICURE B.V.' has been incorporated in Amsterdam, Netherlands. This letter is being sent in compliance with the provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and all other SEBI Regulations as applicable. Announcement under Regulation 30 (LODR)-Cessation
Dear Sir, We would like to inform you that Mr. Neeraj Raghuvanshi has resigned as Chief Operating Officer (COO) w.e.f. 31st May, 2018. The above is for your information and record. Board Meeting-Appointment of Director
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors at their meeting held on 10th May, 2018 have appointed Mr. Alessandro Balboni (DIN 08119143) an Italian National as an Additional Director to hold office till the date of the ensuing Annual General Meeting of the Company.... Board recommends Final Dividend
Poly Medicure Ltd has informed BSE that the Board of Directors at their meeting held on May 10, 2018, inter alia, has approved the following businesses: - Recommendation of Final Dividend of Rs. 2 (Two Rupee) per Equity Shares (40%) of Rs. 5 each for the Financial Year 2017-18 subject to approval of shareholders. Board Meeting-Outcome of Board Meeting
Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 10th May, 2018, at EROS Hotels, Nehru Place, New Delhi - 110019, approved the following businesses: a) Audited Financial Results (Consolidate & Standalone) for the year ended on 31st March 2018....